Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Olink Proteomics

Explore full profile

Develops ground-breaking technologies for biomolecular analysis

Uppsala kommun, SwedenFounded 2016Biotech & Life Sciences
Valuation $3.16B Market cap · 2024
Revenue $251M Latest reported FY

About Olink Proteomics

Olink operates in the biotechnology sector, specializing in proteomics, which is the large-scale study of proteins. The company provides highly sensitive and accurate protein quantification solutions, empowering scientists to investigate complex biological processes with precision. Olink's core product, Olink Explore HT, allows for the measurement of 5,400 proteins, facilitating the understanding of disease at the protein level. The company serves a diverse range of clients, including academic researchers, pharmaceutical companies, and healthcare institutions. By integrating proteomics with genomics, Olink aims to accelerate the discovery of novel drug targets and advance disease understanding and therapy development. The business model is primarily B2B (business-to-business), generating revenue through the sale of its proteomics solutions and related services. Olink's innovative technology supports population-scale studies and real-time biology, providing actionable insights into human health and disease.

Source: Dealroom company data

At a glance

Status
Listed
Founded
2016
Headquarters
Uppsala kommun, Sweden
Listing
IPO 2019
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later3 investors entered at this stage

Employees mapped 557 incl. 26 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 10 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
20 countries with
team presence
🇸🇪 Sweden64.7%
🇺🇸 United States15.5%
🇬🇧 United Kingdom5.1%
🇩🇪 Germany4.3%
🇫🇷 France1.7%
Top 5 of 20 shown
Web traffic by country
55K monthly visits
across markets
🇺🇸 United States40.2%
🇩🇰 Denmark17.6%
🇬🇧 United Kingdom6.4%
🇸🇪 Sweden6.4%
🏳️ Korea5.3%
Top 5 markets shown

Patents

Estimated portfolio value
$8M

13 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Olink Proteomics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Olink Proteomics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.